Quality Systems

FDA Quality Management Maturity (QMM)

What FDA's voluntary QMM appraisal program evaluates, and how a maturity rating may influence inspection posture.

What this course covers

This course covers what FDA's Quality Management Maturity program is and how the voluntary appraisal process works, the maturity domains FDA evaluates a site against, how a QMM rating may influence inspection frequency and regulatory posture, and how QMM relates to and differs from ICH Q10's pharmaceutical quality system model.

Who this course is for

Site quality leadership evaluating whether to pursue a QMM appraisal
Anyone benchmarking a site's quality system maturity against FDA's framework

What you'll learn

What FDA's Quality Management Maturity program is and how the voluntary appraisal works
The maturity domains FDA evaluates a site against
How a QMM rating may influence inspection frequency and regulatory posture
How QMM relates to and differs from ICH Q10's pharmaceutical quality system model
What a site should have in place before pursuing a QMM appraisal

Why it matters

QMM represents a shift in how FDA thinks about oversight, moving from a purely compliance-based inspection model toward rewarding demonstrated maturity. Sites that understand the framework early have a head start on a program still gaining adoption across the industry.

Included in the full GMPify subscription

Completion certificate, PDF slide download, and access to the complete GMP course library from day one.

Start this course →